GeneDx Holdings Corp.WGSNASDAQ
Loading
WGS Revenue Growth (YoY Quarterly)•+26.50%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+26.50%
-25.4pp
+19.21%
-57.5pp
-175.39%
-175.4pp
-255.79%
-255.8pp
-424.86%
-424.9pp
-405.00%
-405.0pp
-395.00%
-395.0pp
-0.38%
-6.7pp
-0.38%
-6.7pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +66.57% | +39.56% | +45.63% | +51.86% | +26.50% |
| Gross Profit Growth | +115.27% | +56.31% | +65.07% | +76.73% | +19.21% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | -175.39% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | -255.79% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | -424.86% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | -405.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | -395.00% |
| Weighted Average Shares Growth | +3.91% | +8.00% | +7.37% | +6.28% | -0.38% |
| Weighted Average Shares Diluted Growth | +3.91% | +8.00% | +11.78% | +6.28% | -0.38% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +14.67% | +59.25% | +83.36% | +58.36% | +97.64% |
| Inventory Growth | +21.34% | +9.01% | +15.60% | -1.87% | +31.00% |
| Asset Growth | +0.15% | +13.16% | +19.21% | +20.81% | +35.96% |
| Book Value per Share Growth | +3.51% | +15.02% | +33.02% | +34.47% | +26.14% |
| Debt Growth | -3.01% | -6.79% | -2.20% | -2.53% | +30.80% |
| R&D Expense Growth | -5.39% | +8.73% | +39.09% | +69.99% | +107.39% |
| SG&A Expenses Growth | +6.73% | +27.71% | +10.05% | +57.40% | +65.33% |
1 / 4